Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Treatment Options in Neurology

15-03-2024 | Stroke | Review

Ethical Considerations in the Treatment of Cerebrovascular Disease

Author: Nathan A. Shlobin, BA

Published in: Current Treatment Options in Neurology

Login to get access

Abstract

Purpose of Review

To care for patients with cerebrovascular disease (CVD), neurointerventionalists, intensivists, and other healthcare providers must be equipped to address associated ethical challenges. This review aims to delineate the applicability of fundamental bioethical approaches to CVD, highlight key ethical issues in CVD care, and delineate an ethical framework to streamline ethical decision-making for people with CVD.

Recent Findings

Three introductory cases are presented. The four key principles of principalism and the approach of narrative ethics are described with reference to CVD. Key ethical considerations include decision-making capacity and informed consent, uncertainty, and resource allocation. A categorization of CVD as emergent/nonemergent and the recommended management as intervention/no intervention helps frame the spectrum of CVD. A different six-pathway may then be taken based on which category the patient case corresponds to.

Summary

Physicians involved in the care of people with cerebrovascular disease must understand how the ethical issues manifest in individual patient cases to ensure appropriate care. The aforementioned ethical framework may aid physicians in providing ethically sound care. All decisions must involve a balance between clinical expertise and patient values and preferences or those articulated by a surrogate to properly respect the wishes of patients with CVD.
Literature
1.
Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981–86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 1990;53(1):16.
2.
Schoenberg BS, Mellinger JF, Schoenberg DG. Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology. 1978;28(8):763-.
3.
Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67–492.CrossRefPubMed
4.
5.
Bravata DM, Ho S-Y, Brass LM, Concato J, Scinto J, Meehan TP. Long-term mortality in cerebrovascular disease. Stroke. 2003;34(3):699–704.CrossRefPubMed
6.
Portegies M, Koudstaal P, Ikram M. Cerebrovascular disease. Handb Clin Neurol. 2016;138:239–61.PubMed
7.
8.
•• Shlobin NA, Clark JR, Campbell JM, Bernstein M, Jahromi BS, Potts MB. Ethical considerations in surgical decompression for stroke. Stroke. 2022;53(8):2673–82. Comprehensive description of the ethical considerations of decompressive craniectomy for stroke by the author of this article.
9.
O’Neill O. Some limits of informed consent. The Elderly. Routledge; 2017. p. 103–6.
10.
Shlobin NA, Rosenow JM. Ethical considerations in the implantation of neuromodulatory devices. Neuromodulation: technology at the neural interface. 2021.
11.
Shlobin NA, Campbell JM, Rosenow JM, Rolston JD. Ethical considerations in the surgical and neuromodulatory treatment of epilepsy. Epilepsy Behav. 2022;127: 108524.CrossRefPubMedPubMedCentral
12.
Salwi S, Kelly KA, Patel PD, Fusco MR, Mistry EA, Mistry AM, et al. Neighborhood socioeconomic status and mechanical thrombectomy outcomes. J Stroke Cerebrovasc Dis. 2021;30(2): 105488.CrossRefPubMed
13.
• Regenhardt RW, Young MJ, Etherton MR, Das AS, Stapleton CJ, Patel AB, et al. Toward a more inclusive paradigm: thrombectomy for stroke patients with pre-existing disabilities. J Neurointerv Surg. 2020. Study indicated that individuals with pre-existing disabilities should not be systematically excluded from undergoing mechanical thrombectomy for stroke.
14.
Leker RR, Gavriliuc P, Yaghmour NE, Gomori JM, Cohen JE. Increased risk for unfavorable outcome in patients with pre-existing disability undergoing endovascular therapy. J Stroke Cerebrovasc Dis. 2018;27(1):92–6.CrossRefPubMed
15.
Howard G, Roubin GS, Jansen O, Hendrikse J, Halliday A, Fraedrich G, et al. Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: a meta-analysis of pooled patient data from four randomised trials. The Lancet. 2016;387(10025):1305–11.CrossRef
16.
17.
Daou B, Hammer C, Mouchtouris N, Starke RM, Koduri S, Yang S, et al. Anticoagulation vs antiplatelet treatment in patients with carotid and vertebral artery dissection: a study of 370 patients and literature review. Neurosurgery. 2017;80(3):368–79.CrossRefPubMed
18.
Investigators CT. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial. Lancet Neurol. 2015;14(4):361–7.CrossRef
19.
Hachem LD, Bernstein M. Ethical issues in geriatric cranial neurosurgery. Neurosurg Focus. 2020;49(4):E3.CrossRefPubMed
20.
Shlobin NA, Sheldon M, Lam S. Informed consent in neurosurgery: a systematic review. Neurosurg Focus. 2020;49(5):E6.CrossRefPubMed
21.
McGehrin K, Spokoyny I, Meyer BC, Agrawal K. The COAST stroke advance directive: a novel approach to preserving patient autonomy. Neurol Clin Pract. 2018;8(6):521–6.
22.
Bryant J, Skolarus LE, Smith B, Adelman EE, Meurer WJ. The accuracy of surrogate decision makers: informed consent in hypothetical acute stroke scenarios. BMC Emerg Med. 2013;13(1):1–6.CrossRef
23.
Alonso A, Dörr D, Szabo K. Critical appraisal of advance directives given by patients with fatal acute stroke: an observational cohort study. BMC Med Ethics. 2017;18(1):1–9.CrossRef
24.
Spokoyny I, Cederquist L, Clay B, Meyer BC. COAST (coordinating options for acute stroke therapy): an advance directive for stroke. J Clin Ethics. 2015;26(3):206–11.CrossRefPubMed
25.
Klein A, Kuehner C, Schwarz S. Attitudes in the general population towards hemi-craniectomy for middle cerebral artery (MCA) infarction. A population-based survey. Neurocritical Care. 2012;16(3):456–61.CrossRefPubMed
26.
Creutzfeldt CJ, Schubert GB, Tirschwell DL, Longstreth Jr W, Becker KJ. Risk of seizures after malignant MCA stroke and decompressive hemicraniectomy. Am Heart Assoc. 2012.
27.
Hamilton MG. Daily neurosurgical experiences with ethics and the elderly. Neurosurg Focus. 2020;49(4):E4.CrossRefPubMed
28.
Qureshi AI, Gilani S, Adil MM, Majidi S, Hassan AE, Miley JT, et al. Pattern of informed consent acquisition in patients undergoing emergent endovascular treatment for acute ischemic stroke. J Vasc Interv Neurol. 2014;7(2):21.PubMedPubMedCentral
29.
Rosenbaum JR, Bravata DM, Concato J, Brass LM, Kim N, Fried TR. Informed consent for thrombolytic therapy for patients with acute ischemic stroke treated in routine clinical practice. Stroke. 2004;35(9):e353–5.CrossRefPubMed
30.
Shlobin NA, Huang J, Lam S. Health literacy in neurosurgery: a scoping review. World Neurosurg. 2022.
31.
Shlobin NA, Clark JR, Hoffman SC, Hopkins BS, Kesavabhotla K, Dahdaleh NS. Patient education in neurosurgery: part 1 of a systematic review. World Neurosurg. 2020.
32.
Shlobin NA, Clark JR, Hoffman SC, Hopkins BS, Kesavabhotla K, Dahdaleh NS. Patient education in neurosurgery: part 2 of a systematic review. World Neurosurg. 2020.
33.
Stein J, Brady Wagner LC. Is informed consent a “yes or no” response? Enhancing the shared decision-making process for persons with aphasia. Top Stroke Rehabil. 2006;13(4):42–6.CrossRefPubMed
34.
Clark JR, Shlobin NA, Batra A, Liotta EM. The relationship between limited English proficiency and outcomes in stroke prevention, management, and rehabilitation: a systematic review. Front Neurol. 2022;13:77.CrossRef
35.
Schwamm LH. Acute stroke: shifting from informed consent to informed refusal of intravenous tissue-type plasminogen activator. Am Heart Assoc. 2015;S69-S72.
36.
Creutzfeldt CJ, Holloway RG. Treatment decisions after severe stroke: uncertainty and biases. Stroke. 2012;43(12):3405–8.CrossRefPubMed
37.
Schwarze ML, Sayla MA, Alexander GC. A comparison of patient and physician beliefs about infrainguinal bypass operation: what role should surgical optimism play? Surgery. 2007;141(2):239–44.CrossRefPubMed
38.
Fargen KM, Leslie-Mazwi TM, Chen M, Hirsch JA. Physician, know thyself: implicit and explicit decision-making for mechanical thrombectomy in stroke. J NeuroInterv Surg. 2020.
39.
Aghabarary M, Nayeri ND. Medical futility and its challenges: a review study. J Med Ethics Hist Med. 2016;9.
40.
41.
Frick S, Uehlinger DE, Zenklusen RMZ. Medical futility: predicting outcome of intensive care unit patients by nurses and doctors—a prospective comparative study. Crit Care Med. 2003;31(2):456–61.CrossRefPubMed
42.
Venermo M, Wang G, Sedrakyan A, Mao J, Eldrup N, DeMartino R, et al. Editor’s choice–carotid stenosis treatment: variation in international practice patterns. Eur J Vasc Endovasc Surg. 2017;53(4):511–9.CrossRefPubMed
43.
44.
Cox AM, McKevitt C, Rudd AG, Wolfe CD. Socioeconomic status and stroke. Lancet Neurol. 2006;5(2):181–8.CrossRefPubMed
45.
Addo J, Ayerbe L, Mohan KM, Crichton S, Sheldenkar A, Chen R, et al. Socioeconomic status and stroke: an updated review. Stroke. 2012;43(4):1186–91.CrossRefPubMed
46.
Maruthappu M, Shalhoub J, Tariq Z, Williams C, Atun R, Davies AH, et al. Unemployment, government healthcare spending, and cerebrovascular mortality, worldwide 1981–2009: an ecological study. Int J Stroke. 2015;10(3):364–71.CrossRefPubMed
47.
Saposnik G, Menon BK, Kashani N, Wilson AT, Yoshimura S, Campbell BC, et al. Factors associated with the decision-making on endovascular thrombectomy for the management of acute ischemic stroke. Stroke. 2019;50(9):2441–7.CrossRefPubMed
Metadata
Title
Ethical Considerations in the Treatment of Cerebrovascular Disease
Author
Nathan A. Shlobin, BA
Publication date
15-03-2024
Publisher
Springer US
Published in
Current Treatment Options in Neurology
Print ISSN: 1092-8480
Electronic ISSN: 1534-3138
DOI
https://doi.org/10.1007/s11940-024-00789-4